New Antidiabetic Drugs and Cardiovascular Outcomes

Course Preview
  • Skill Levelexpert
  • Lectures1 Video
  • Enrolled 1,028 students enrolled
Enquire now

Key concepts covered include:

By the end of this course, you will be able to understand:

  • A closure look at CV effects of 21st century T2D agent
  • CV Safety trials are being conducted for each compound within newer classes
  • CVOTs with SGLT2 inhibitors
  • Recommendations for Glucose-Lowering treatment in DM1

What you'll learn

Until very recently antidiabetic drugs were prescribed just in order to regulate glucose levels and delay diabetes complications but with no direct benefit and with possible harms. The new antidiabetic drug generations provide also direct cardiovascular benefits with the short-term reduction of CV mortality. Clinical cardiologists should know which drug class suits which patient.

Who Should Attend?

  • General practitioners
  • Primary care physicians
  • Clinical Cardiologists
  • Diabetologists

Instructor

Dr. Dimitri Richter

President of the Council for cardiology practice at European Society of Cardiology, Greece.


4/5

“Dr. Richter is the President of the Council for cardiology practice at European Society of Cardiology, Greece. He was the General Secretary of Hellenic Lipidology Society 2007-2013, and President from 2013- today, and also Member of the board of Hellenic Heart Foundation since 2009. He is currently working as a Vice-president of the Hellenic College of Metabolic diseases since 2011.

He was a Member of the board of Hellenic Antihypertensive society 2009-2011. He worked as a Vice-president WG epidemiology and Prevention – Hellenic Heart Society2006-2007 and also President WG epidemiology and Prevention – Hellenic Heart Society 2008-2009., He is the Editor in chief of “Heart and Vessels”, the official publication of the Hellenic Heart Foundation. He Invited as a speaker at national and international congresses more than 600 times. He is the author of 6 chapters in cardiology books, published 180 abstracts in national and international congresses, he is also an Abstract reviewer ESC Annual Congress 2000, 2006-16.”

Course Preview

Instructor

Dr. Dimitri Richter

President of the Council for cardiology practice at European Society of Cardiology, Greece.


4/5

“Dr. Richter is the President of the Council for cardiology practice at European Society of Cardiology, Greece. He was the General Secretary of Hellenic Lipidology Society 2007-2013, and President from 2013- today, and also Member of the board of Hellenic Heart Foundation since 2009. He is currently working as a Vice-president of the Hellenic College of Metabolic diseases since 2011.

He was a Member of the board of Hellenic Antihypertensive society 2009-2011. He worked as a Vice-president WG epidemiology and Prevention – Hellenic Heart Society2006-2007 and also President WG epidemiology and Prevention – Hellenic Heart Society 2008-2009., He is the Editor in chief of “Heart and Vessels”, the official publication of the Hellenic Heart Foundation. He Invited as a speaker at national and international congresses more than 600 times. He is the author of 6 chapters in cardiology books, published 180 abstracts in national and international congresses, he is also an Abstract reviewer ESC Annual Congress 2000, 2006-16.”

For: experts

Certificate

certificate
Last Updated 08/2021

Other Top Rated Courses by Dr. Dimitri Richter

Our alumni and partners

X
or
or

Have an account?